Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 25† | 147† | 104† | 131† | 137† |
| Net profit | — | — | -22† | — | -5† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Ganesh Suresh Potdar | Executive Director | March 31, 2026 |
| Omkar Pravin Herlekar | Executive Director | March 31, 2026 |
| Ketan Bhau Songal | Independent Director | March 31, 2026 |
| Pravin Gadalya Lachake | Independent Director | March 31, 2026 |
| Rekha Hemant Wakh | Independent Director | March 31, 2026 |
| Yogesh Hari Ughada | Independent Director | March 31, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
